At this point, the appetite suppression effects become more noticeable
Stay in contact with your clinical team, 3
These programs are designed for sustainable, long-term success, empowering customers to lose up to 20% of their body weight
It belongs to the family of GLP-1 receptor agonists (GLP-1-RA), initially used for the treatment of people with obesity-associated type 2 diabetes and later for people with obesity without diabetes, commercialised for use in obesity under the name Wegovy
Because of its ability to promote weight loss and improve blood sugar management, semaglutide has become an important treatment for both diabetes and obesity
Most people start seeing weight loss within the first few weeks of treatment with tirzepatide and semaglutide